These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 26159264)

  • 1. Pathophysiology of Liver Fibrosis.
    Pinzani M
    Dig Dis; 2015; 33(4):492-7. PubMed ID: 26159264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver fibrosis: from the bench to clinical targets.
    Pinzani M; Rombouts K
    Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis: a dynamic and potentially reversible process.
    Povero D; Busletta C; Novo E; di Bonzo LV; Cannito S; Paternostro C; Parola M
    Histol Histopathol; 2010 Aug; 25(8):1075-91. PubMed ID: 20552556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
    Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A
    Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular mechanisms in liver fibrogenesis.
    Novo E; Cannito S; Paternostro C; Bocca C; Miglietta A; Parola M
    Arch Biochem Biophys; 2014 Apr; 548():20-37. PubMed ID: 24631571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrosis.
    Wallace K; Burt AD; Wright MC
    Biochem J; 2008 Apr; 411(1):1-18. PubMed ID: 18333835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
    Wasmuth HE; Lammert F; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fibrosis - mouse models and relevance in human liver diseases.
    Mederacke I
    Z Gastroenterol; 2013 Jan; 51(1):55-62. PubMed ID: 23315652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrosis in the liver: acute protection and chronic disease.
    Lee Y; Friedman SL
    Prog Mol Biol Transl Sci; 2010; 97():151-200. PubMed ID: 21074733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.
    Parola M; Marra F; Pinzani M
    Mol Aspects Med; 2008; 29(1-2):58-66. PubMed ID: 18022682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic fibrogenesis: from within and outwith.
    Henderson NC; Forbes SJ
    Toxicology; 2008 Dec; 254(3):130-5. PubMed ID: 18824072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues.
    Parola M; Pinzani M
    Mol Aspects Med; 2019 Feb; 65():37-55. PubMed ID: 30213667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules.
    Gressner AM
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():5-16. PubMed ID: 1449018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis.
    Rombouts K; Marra F
    Dig Dis; 2010; 28(1):229-35. PubMed ID: 20460917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
    Svegliati-Baroni G; De Minicis S; Marzioni M
    Liver Int; 2008 Sep; 28(8):1052-64. PubMed ID: 18783548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Regression of Cirrhosis.
    Saffioti F; Pinzani M
    Dig Dis; 2016; 34(4):374-81. PubMed ID: 27170391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.
    Iwaisako K; Brenner DA; Kisseleva T
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):65-8. PubMed ID: 22320919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells.
    Knight V; Tchongue J; Lourensz D; Tipping P; Sievert W
    Hepatology; 2012 Mar; 55(3):879-87. PubMed ID: 22095855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of liver fibrosis: role of oxidative stress.
    Poli G
    Mol Aspects Med; 2000 Jun; 21(3):49-98. PubMed ID: 10978499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis.
    Perugorria MJ; Latasa MU; Nicou A; Cartagena-Lirola H; Castillo J; Goñi S; Vespasiani-Gentilucci U; Zagami MG; Lotersztajn S; Prieto J; Berasain C; Avila MA
    Hepatology; 2008 Oct; 48(4):1251-61. PubMed ID: 18634036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.